Water Street Healthcare Partners has made an investment in Irvine, California-based Pathnostics, a provider of diagnostic solutions. No financial terms were disclosed. CHICAGO, Feb. 27, 2019 ...
Scott Garrett, former chairman and chief executive at Brea-based Beckman Coulter Inc., believes Irvine-based Pathnostics is a winner in urology diagnostics. Garrett, who left Beckman in 2010, is ...
Pathnostics of Irvine unveiled a molecular diagnostic test that can detect COVID-19, influenza A/B and respiratory syncytial virus with a nasal swab sample and a single test panel. The company ...
Private-equity firm Water Street Healthcare Partners invested in medical diagnostics company Pathnostics, the health care-focused firm’s fifth investment in the diagnostics sector, according to a news ...
Unique partnership underscores both companies' commitment to clinical excellence by achieving improved patient outcomes, reduced healthcare costs, and better patient and provider experiences in the ...
IRVINE, Calif., July 24, 2019 /PRNewswire/ -- Pathnostics, a diagnostic solutions company, announced today that its board of directors has appointed Samuel D. Riccitelli as chief executive officer, ...
IRVINE, Calif., May 2, 2023 /PRNewswire/ -- Pathnostics, a leading precision diagnostic testing and development company, today announced publication of data from the Company's interim analysis for a ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company also is expanding ...
IRVINE, Calif., Oct. 11, 2023 /PRNewswire/ -- Pathnostics, a leading diagnostic solutions company, announced today the publication of clinical study results showing that its advanced urinary tract ...
(MENAFN- PR Newswire) Approval Broadens Patient Access to Company's Advanced Test Enabling Rapid and Precise Diagnosis of Complicated Urinary Tract Infections IRVINE, Calif., Oct. 4, 2023 /PRNewswire/ ...
SAN DIEGO and Irvine, Calif., June 19, 2018 /PRNewswire/ -- GenomeDx Biosciences and Pathnostics today announced the launch of the next generation Guidance testing for patients suffering from simple ...